Chelsea Worldwide Inc. (22)

Browse by Contract Category

Contracts

Second Amendment to Loan and Security Agreement, dated August 9, 2022, by and between Clene Inc., Clene Nanomedicine, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 15, 2022)
Disbursement Agreement, dated May 17, 2022, by and between Clene Nanomedicine, Inc. and the Department of Housing of Community Development, a principal department of the State of... (Filed With SEC on May 19, 2022)
Description of Securities of the Registrant (Filed With SEC on March 11, 2022)
Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Robert Etherington (Filed With SEC on February 2, 2022)
Lease Agreement, dated as of August 10, 2021, between Clene Nanomedicine, Inc. and Upper Chesapeake Flex One, LLC (Filed With SEC on August 11, 2021)
Amended and Restated Promissory Note, dated July August 5, 2022, by Clene Nanomedicine, Inc. to the Department of Housing and Community Development, a principal department of the... (Filed With SEC on August 15, 2022)
Promissory Note, dated May 17, 2022, by Clene Nanomedicine, Inc. to the Department of Housing of Community Development, a principal department of the State of Maryland (Filed With SEC on May 19, 2022)
Security Agreement, dated May 17, 2022, by Clene Nanomedicine, Inc. in favor of the Department of Housing of Community Development, a principal department of the State of Maryland (Filed With SEC on May 19, 2022)
Equity Distribution Agreement, dated April 14, 2022, by and among Clene Inc. and Canaccord Genuity LLC and Oppenheimer & Co. Inc (Filed With SEC on April 14, 2022)
Amendment to Supplement to Loan and Security Agreement, dated as of February 11, 2022, among Clene Inc., Clene Nanomedicine, Inc., and Avenue Venture Opportunities Fund, L.P (Filed With SEC on March 11, 2022)
Amendment to Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Dr. Robert Glanzman (Filed With SEC on February 2, 2022)
Form of Executive Employment Agreement (Filed With SEC on February 2, 2022)
Retention and Separation Agreement and General Release, dated February 1, 2022, by and between Clene Inc. and Dr. Tae Heum (Ted) Jeong (Filed With SEC on February 2, 2022)
Employment Agreement, dated February 1, 2022, by and between Clene Inc. and Morgan Brown (Filed With SEC on February 2, 2022)
Lease Agreement, dated as of August 10, 2021, between Clene Nanomedicine, Inc. and 100 Chesapeake Blvd LLC (Filed With SEC on August 11, 2021)
First Amendment to the Loan and Security Agreement, dated as of June 30, 2021, between Clene Inc., Clene Nanomedicine, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on August 9, 2021)
Form of Subscription Agreement (Filed With SEC on May 24, 2021)
Form of Avenue Venture Opportunities Fund, L.P. Warrant to Purchase Shares of Stock of Clene Inc (Filed With SEC on May 24, 2021)
Supplement to the Loan and Security Agreement, dated as of May 21, 2021, among Client Inc., Clene Nanomedicine, Inc., and Avenue Venture Opportunities Fund, L.P (Filed With SEC on May 24, 2021)
Loan and Security Agreement, dated as of May 21, 2021, between Clene Inc., Clene Nanomedicine, Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on May 24, 2021)
Clene Inc. Board of Directors Compensation Program (Filed With SEC on April 22, 2021)
2020 Equity Incentive Plan (Filed With SEC on January 5, 2021)